IBJNews

Lilly imaging drug fails to win FDA panel's backing

Back to TopCommentsE-mailPrintBookmark and Share

Eli Lilly and Co. failed to win a U.S. panel’s backing for a new drug to help identify plaque in the brain tied to Alzheimer’s disease.

Lilly’s Amyvid isn’t ready to be approved to detect beta-amyloid plaque deposits in the brain, outside advisers to the Food and Drug Administration said Thursday in a 13-3 vote at the agency’s headquarters in Silver Spring, Md. The panel unanimously agreed that the medicine can be approved if Lilly establishes a training program and a way to ensure that the results of brain scans are read consistently.

Lilly, based in Indianapolis, acquired Amyvid in its $300 million purchase of closely held Avid Radiopharmaceuticals in December. While the FDA usually follows the recommendations of its advisory panels, it isn’t required to do so.

“We appreciate the careful and thoughtful review of our data today by the committee,” said Daniel M. Skovronsky, chief executive officer of Lilly’s Avid subsidiary, in a statement. “We are encouraged that they recommended a clear path toward approval.”

ADVERTISEMENT

Post a comment to this story

COMMENTS POLICY
We reserve the right to remove any post that we feel is obscene, profane, vulgar, racist, sexually explicit, abusive, or hateful.
 
You are legally responsible for what you post and your anonymity is not guaranteed.
 
Posts that insult, defame, threaten, harass or abuse other readers or people mentioned in IBJ editorial content are also subject to removal. Please respect the privacy of individuals and refrain from posting personal information.
 
No solicitations, spamming or advertisements are allowed. Readers may post links to other informational websites that are relevant to the topic at hand, but please do not link to objectionable material.
 
We may remove messages that are unrelated to the topic, encourage illegal activity, use all capital letters or are unreadable.
 

Messages that are flagged by readers as objectionable will be reviewed and may or may not be removed. Please do not flag a post simply because you disagree with it.

Sponsored by
ADVERTISEMENT

facebook - twitter on Facebook & Twitter

Follow on TwitterFollow IBJ on Facebook:
Follow on TwitterFollow IBJ's Tweets on these topics:
 
Subscribe to IBJ
ADVERTISEMENT